Results 201 to 210 of about 25,531,432 (247)
Suspected fibrosing cholestatic hepatitis in an immunocompetent child with hepatitis C: Case report
Abstract A 12‐year‐old boy presented to our center with elevated aminotransferases, jaundice, right upper quadrant tenderness, and hepatomegaly. Evaluation revealed a highly elevated blood hepatitis C virus (HCV) ribonucleic acid (RNA) level, and liver biopsy showed canalicular and intrahepatic cholestasis, feathery degeneration of hepatocytes, and ...
Sara Bohon +5 more
wiley +1 more source
Abstract Drug‐induced vanishing bile duct syndrome (VBDS) is a rare complication of severe cholestatic hepatitis characterized by progressive ductopenia despite withdrawal of the offending agent. Prognosis ranges from gradual recovery to liver failure requiring transplantation. We report the first known pediatric case of biopsy‐confirmed VBDS following
Kathryn Kaihlanen +5 more
wiley +1 more source
Abstract We report a patient with Hoyeraal–Hreidarsson syndrome (HHS), a telomere biology disorder, who developed severe chronic enterocolitis with inflammatory bowel disease‐like features. Vedolizumab led to improvement in stool frequency, reduced fecal calprotectin, and clinical remission without infectious complications.
Yasutaka Chiba +6 more
wiley +1 more source
Abstract Haploinsufficiency of A20 (HA20) is a rare autoinflammatory disorder caused by heterozygous loss‐of‐function variants in tumor necrosis factor alpha‐induced protein 3 (TNFAIP3), encoding a negative regulator of nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NFκB) signaling.
Amanda Blake +5 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Nature Reviews Disease Primers, 2017
Hepatitis C virus (HCV) is a hepatotropic RNA virus that causes progressive liver damage, which might result in liver cirrhosis and hepatocellular carcinoma. Globally, between 64 and 103 million people are chronically infected. Major risk factors for this blood-borne virus infection are unsafe injection drug use and unsterile medical procedures ...
Zobair Younossi +2 more
exaly +5 more sources
Hepatitis C virus (HCV) is a hepatotropic RNA virus that causes progressive liver damage, which might result in liver cirrhosis and hepatocellular carcinoma. Globally, between 64 and 103 million people are chronically infected. Major risk factors for this blood-borne virus infection are unsafe injection drug use and unsterile medical procedures ...
Zobair Younossi +2 more
exaly +5 more sources
New England Journal of Medicine, 2001
Hepatitis C virus (HCV) infects an estimated 170 million persons worldwide and thus represents a viral pandemic, one that is five times as widespread as infection with the human immunodeficiency virus type 1 (HIV-1). The institution of blood-screening measures in developed countries has decreased the risk of transfusion-associated hepatitis to a ...
Georg M Lauer
exaly +3 more sources
Hepatitis C virus (HCV) infects an estimated 170 million persons worldwide and thus represents a viral pandemic, one that is five times as widespread as infection with the human immunodeficiency virus type 1 (HIV-1). The institution of blood-screening measures in developed countries has decreased the risk of transfusion-associated hepatitis to a ...
Georg M Lauer
exaly +3 more sources
Antibodies to hepatitis C virus and hepatitis C virus infection
Gastroenterologia Japonica, 1993The authors studied the interrelationship of antibody to hepatitis C virus core protein (anti-HCV core), antibody to C100-3 antigen (anti-C100-3) and serum hepatitis C virus RNA positivity in chronic liver disease patients. Anti-HCVcore was detected with high titers in 95% (69/73) of chronic non-A, non-B hepatitis patients, while anti-C100-3 was found ...
N, Yuki +5 more
openaire +2 more sources
Hepatitis C virus infection and cryoglobulinemia
Journal of Hepatology, 1998Mixed cryoglobulins (CG) are serum proteins that precipitate at low temperature and are commonly classified into two types according to the presence (type II) or not (type III) of monoclonal immunoglobulins. Mixed CG are observed in a wide variety of diseases.
F, Lunel, L, Musset
openaire +3 more sources
Prevention of hepatitis C virus infection*
Journal of Viral Hepatitis, 2004Summary.In spite of advances made in our understanding of the biology of the hepatitis C virus (HCV), the epidemiology and natural history of HCV infection, and the treatment of chronic hepatitis C, the development and worldwide implementation of a comprehensive prevention and control strategy remains necessary.
Kew, M. +9 more
openaire +3 more sources

